Galmed Pharmaceuticals Ltd. ( GLMD) - Stock Earnings
GLMD Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| July 30, 2026, midnight | — / — | — | — / — | — |
GLMD Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q1 | -1.1 million USD | — USD |
| 2025Q2 | -2.5 million USD | — USD |
| 2025Q3 | -1.9 million USD | — USD |
GLMD Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2022 | -18.6 million USD | 0 USD |
| 2023 | -6.9 million USD | — USD |
| 2024 | -7.5 million USD | — USD |
| 2026 Est. | — | — |
GLMD
Price: $0.51
52 week price:
Earnings Per Share: -3.44 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: Israel
Volume: 176487
Ebitda: -2.7 millionMarket Capitalization: 3.1 million